The warfarin (coumarin)-embryopathy - a re-emergence of this syndrome? A case report

被引:1
|
作者
Rummler, S
Schulze, R
Leeder, B
Kassem, R
机构
[1] Stadt Krankenhaus Eisenhuttenstadt GmbH, Abt Frauenheilkunde & Geburtshilfe, D-15872 Eisenhuttenstadt, Germany
[2] Stadt Krankenhaus Eisenhuttenstadt GmbH, Abt Kinder & Jugendmed, D-15872 Eisenhuttenstadt, Germany
关键词
surveillance in gestation; oral anticoagulans in gestation; warfarin-embryopathy;
D O I
10.1055/s-2003-37099
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This is a case report of a 3210 g girl infant born with a nasal hypoplasia as a sign of the fetal (coumarin)warfarin-syndrome. Her mother - a 30-years-old II. gravida with a past history of thrombosis - had received Phenprocoumon (Falithrom(R)) [3 - 4,5 mg daily] for post-thrombose-prophylaxis during pregnancy up to the 23rd week of gestation. Teratogens like the (oral anticoagulans) Phenprocoumon may produce that disease, therefore Coumarin (Warfarin) should not be used in pregnancy, furthermore, women should be advised to take precautions against conception while taking that pharmacon.
引用
收藏
页码:70 / 73
页数:4
相关论文
共 50 条